Skip to content

Clinical trials

Enrolling by invitation Lung Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Enrolling by invitation Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20212
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center1
Harvard Medical School (HMS and HSDM)1
Icahn School of Medicine at Mount Sinai1
National Cancer Institute (NCI)1
Rush University Medical Center1
Stanford University1
Tobias Moeller-Bertram1
University of California, Irvine1
VA Office of Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms9
Pulmonary Disease, Chronic Obstructive3
Brain Neoplasms2
Amyotrophic Lateral Sclerosis1
Angina, Stable1
Anxiety Disorders1
Arthritis, Rheumatoid1
Asthma1
Atrial Fibrillation1
Breast Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.